The UAE oncology clinical trials market is projected to grow from $63.3 Mn in 2022 to $104.7 Mn by 2030, registering a CAGR of 6.5% during the forecast period of 2022-30. The market will be driven by the rising rate of cancer in the UAE and investments in developing healthcare infrastructure and research capabilities to support the field. The market is segmented by phase, study design, and indication. Some of the major players include Pfizer Inc, FHoffmann-La Roche Ltd & Julphar
The UAE oncology clinical trials market is projected to grow from $63.3 Mn in 2022 to $104.7 Mn by 2030, registering a CAGR of 6.5% during the forecast period of 2022-30. Over 400 clinical research trials are now underway in Abu Dhabi. According to Globocan 2020, out of a total population of 98,90,400 number of new cases of cancer in UAE was 4,807. 21.4% of which accounted for breast cancer, 10.6% for colorectal cancer, and 8.4% for thyroid cancer.
Oncology clinical trials entail evaluating novel cancer therapies or combinations of treatments to establish their safety and efficacy. A variety of clinical trials in cancer are now underway in the UAE, which is mainly undertaken by hospitals, research organizations, or pharmaceutical corporations. In recent years, the UAE has made considerable efforts in strengthening its healthcare infrastructure and research capacity, notably in cancer. To conduct clinical studies and enhance cancer treatment, the government has formed alliances with renowned international institutes.
Trials for new cancer drugs, studies of novel therapies such as immunotherapy, and investigations into the use of advanced technologies such as robotics and artificial intelligence in cancer treatment are among the clinical trials in oncology that have been conducted or are currently underway in the UAE. Various institutions such as Dubai Hospital, Tawam Hospital, Abu Dhabi National Cancer Institute, Gulf International Cancer Center & Mediclinic Middle East conduct clinical trials in oncology. The UAE has also developed regulatory frameworks to guarantee that clinical trials are done in an ethical and international standard manner. The Ministry of Health and Prevention, the country's regulatory authority, controls the approval and supervision of clinical studies in the UAE.
Market Growth Drivers
Cancer incidences in the UAE have increased in recent years, which has increased the need for additional clinical studies to evaluate novel therapies. The UAE has invested in cutting-edge technology like as robotics and artificial intelligence, which will fuel the rise of cancer clinical trials that use these technologies. In the UAE, there is a growing awareness of the advantages of clinical trials, which might motivate more patients to enroll in cancer clinical trials. The UAE government has shown a propensity to spend on healthcare infrastructure and research, which is expected to aid in the expansion of cancer clinical trials. The UAE has formed strategic alliances with prominent worldwide institutions to conduct clinical trials, which is expected to assist fuel the country's development in cancer clinical trials.
Due to the UAE's tiny population, it may be challenging to enroll a sufficient number of patients for clinical studies. Clinical studies may be costly, and the expense of conducting cancer clinical trials in the UAE might limit expansion. Despite government support, funding for cancer clinical trials in the UAE may be restricted. Clinical trials are subject to regulatory regulations, and negotiating these procedures may be difficult and time-consuming, potentially limiting progress. There may be competition for patients and resources from other nations.
1. Report Description of the UAE Oncology Clinical Trials Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. UAE Oncology Clinical Trials Market Executive Summary
2.1 UAE Oncology Clinical Trials Market - Industry Snapshot & key buying criteria, 2022-2030
2.2 Market Size, Growth Prospects, and Key findings
3. Market Dynamics of UAE Oncology Clinical Trials Market
3.1 Market Growth Drivers Analysis
3.2 Market Restrains Analysis
4. UAE Oncology Clinical Trials Market Segmentation
4.1 By Phase
4.1.1 Phase I
4.1.2 Phase II
4.1.3 Phase III
4.1.4 Phase IV
4.2 By Cancer Type
4.2.1 Lung cancer
4.2.2 Breast cancer
4.2.3 Thyroid cancer
4.2.5 Liver cancer
4.2.6 Skin cancer
4.2.8 Pancreatic cancer
4.2.9 Prostate cancer
4.2.10 Colon & rectal cancer
4.2.11 Urinary system cancer
4.2.12 Other cancer
4.3 By Indication Outlook
4.3.3 Expanded Access
5. UAE Oncology Clinical Trials Market Share
5.1 Market Analysis, Insights, and Forecast - By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
7. Key Company Profiles
7.1 Company 1
7.1.2 Financial Performance
7.1.3 Product & Services
7.1.4 Strategic initiatives
7.2 Company 2
7.2.2 Financial Performance
7.2.3 Product & Services
7.2.4 Strategic initiatives
7.3 Company 3
7.3.2 Financial Performance
7.3.3 Product & Services
7.3.4 Strategic initiatives
7.4 Company 4
7.4.2 Financial Performance
7.4.3 Product & Services
7.4.4 Strategic initiatives
7.5 Company 5
7.5.2 Financial Performance
7.5.3 Product & Services
7.5.4 Strategic initiatives
8. Healthcare Policies and Regulatory Landscape
8.1 Healthcare Policies in UAE
8.2 Regulatory Framework in UAE
8.3 Pricing & Reimbursement Scenario in UAE Oncology Clinical Trials Market
9. Factors Driving Future Growth
9.1 New Trends and Development UAE Oncology Clinical Trials Market
9.2 Future Opportunities
10. Strategic Recommendations
By Phase (Revenue, USD Billion):
By Study Design Outlook (Revenue, USD Billion):
By Indication Outlook (Revenue, USD Billion):
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to oﬀer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses